Blinatumomab (active substance) - analogs
Pharmgroups: Antitumor agents - monoclonal antibodies |
|||||||||
Prices in pharmacies: Instructions Blinatumomab | |||||||||
|
ⓘ✘Enter drugs for checking interactions through a quick button search . |
|
ⓘ✘ diseases to evaluate contraindications and side effects through a quick search. |
Начиная работу с сервисом, вы принимаете соглашение пользователя. Kiberis do not replace the doctor!
Blinatumomab included in the composition |
Prices in pharmacies |
Blincyto | 1913.5€ |
-
Similar
Prices in
pharmaciesAnalogs by action ⓘ✘Analogues of the drug according to its degree of similarity with other drugs that are not direct analogues
- 50% Inotuzumab ozogamicin
- 39% Obinutuzumab
- 39% Ofatumumab
- 29% Amsacrine
- 29% Bosutinib
- 28% Dasatinib
- 28% Tioguanine
- 28% Nelarabine
- 24% Molgramostim
- 23% Pegaspargase
- 22% Imatinib
- 22% Elotuzumab
- 22% Catumaxomab
- 21% Mercaptopurine
- 21% Hexaphosphamide
- 20% Venetoclax
- 20% Pertuzumab
- 20% Trastuzumab emtansine
- 20% Avelumab
- 20% Daratumumab
- 20% Ipilimumab
- 20% Durvalumab
- 20% Isatuximab
- 19% Nilotinib
- 18% Trastuzumab
- 17% Cetuximab
- 17% Idarubicin
- 17% Prolgolimab
- 17% Akalabrutinib
- 16% Cytarabine
- 16% Pembrolizumab
- 16% Bevacizumab
- 15% Paphencyl
- 15% Fludarabine
- 15% Prodimin
- 14% Nivolumab
- 14% Asparaginase
- 14% Chlorethylaminouracil
- 13% Lenograstim
- 13% Dipin
- 12% Midostaurin
- 11% Lipegfilgrastim
- 11% Ibrutinib
- 11% Ramucirumab
- 11% Lophenalac
- 10% Febuxostat
- 10% Osimertinib
- 10% Gefitinib
- 10% Ceritinib
- 10% Busulfan
Learn more about the selection of analogues
- The drug has «Blinatumomab» 51 analog by action, the most similar - Inotuzumab ozogamicin .
- Medical online service has selected the best substitutes for Blinatumomab based on its instructions, components, pharmaceutical groups and practical application.
- The table shows the prices of Blinatumomab analogues to choose the cheapest pills.
- If you have introduced other drugs for registration, substitutes are selected taking into account the assessment of interactions and safety.
- Sometimes, due to the presence of dangerous interactions, it is necessary to use drugs that are similar in effect, sometimes even from different pharmacological groups.